TABLE 1.
Characteristic | No. of Patients (%) |
---|---|
Age at diagnosis, median (IQR), y | 60 (55–68) |
Radiation dose, median (IQR), Gy | 70 (66–70.5) |
Sex | |
Male | 1407 (82.8) |
Female | 292 (17.2) |
Period of diagnosis | |
1980–1989 | 133 (7.8) |
1990–1999 | 311 (18.3) |
2000–2013 | 1255 (73.9) |
Smoking status | |
Never | 744 (44.2) |
Former | 571 (33.9) |
Current | 370 (22.0) |
Missing | 14 |
Smoking, pack-years | |
≤10 | 956 (58.4) |
>10 | 680 (41.6) |
Missing | 63 |
Site | |
Tonsil | 773 (45.5) |
Base of tongue | 821 (48.3) |
Other | 105 (6.2) |
HPV status | |
Negative | 48 (10.1) |
Positive | 429 (89.9) |
Missing | 1222 |
T category | |
T1 | 523 (30.8) |
T2 | 639 (37.6) |
T3 | 353 (20.8) |
T4 | 183 (10.8) |
Missing | 1 |
N category (AJCC 7th ed.) | |
N0 | 218 (12.9) |
N1 | 330 (19.4) |
N2 | 1045 (61.5) |
N3 | 105 (6.2) |
Missing | 1 |
Neck dissection | |
No | 1306 (76.9) |
Yes | 393 (23.1) |
IMRT | |
No | 621 (36.6) |
Yes | 1078 (63.4) |
Fractionation | |
Conventional | 1164 (68.7) |
Concomitant boost | 456 (26.9) |
Other | 75 (4.4) |
Missing | 4 |
Radiation dose, Gy | |
>70 | 440 (26.0) |
>66–70 | 622 (36.7) |
≤66 | 633 (37.3) |
Missing | 4 |
Chemotherapy | |
None | 726 (42.7) |
Adjuvant only | 266 (15.7) |
Concurrent only | 485 (28.5) |
Both | 222 (13.1) |
Recurrencea | |
None | 1614 (95.0) |
Local | 53 (3.1) |
Regional | 9 (0.5) |
Distant | 35 (2.1) |
Second primary tumor | |
No | 1408 (84.5) |
Yes | 258 (15.5) |
Missing | 33 |
Abbreviations: AJCC, American Joint Committee on Cancer; HPV, human papillomavirus; IMRT, intensity-modulated radiation therapy; IQR, interquartile range.
Groups not mutually exclusive.